Symbols / FRTX
FRTX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2022-11-10 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
- FRTX Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 01
- FRTX Shareholders to Receive $0.96 Per Share as Company Begins Final Dissolution Process - Stock Titan ue, 25 Feb 2025 08
- FRTX Stock Earnings: Fresh Tracks Therapeutics Reported Results for Q4 2023 - TradingView Mon, 18 Mar 2024 07
- Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis $FRTX - MarketBeat Sat, 10 Sep 2022 09
- New 52-Week Low Could Prompt More Insider Buying At BFS - Nasdaq Wed, 24 Sep 2025 07
- Fresh Tracks to dissolve after hunt for buyer comes up empty - Fierce Biotech ue, 19 Sep 2023 07
- Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update - marketscreener.com hu, 05 Oct 2023 07
- Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics - GlobeNewswire Wed, 07 Sep 2022 07
- Notable ETF Inflow Detected - IWM, BE, CRDO, FN - Nasdaq Wed, 21 Jan 2026 08
- Brickell Biotech, Inc. completed the acquisition of Vical Incorporated from Biotechnology Value Fund L.P., managed by BVF Partners LP in a reverse merger transaction. - marketscreener.com Fri, 30 Aug 2019 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for FRTX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|